Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Kidney Transplantation × Infliximab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Inflammatory Bowel Diseases 2 Crohn Disease 2 Colitis, Ulcerative 2 Lymphoma 1 Kidney Transplantation 1 Hematologic Neoplasms 1 Granulomatous Disease, Chronic 1 Depressive Disorder, Treatment-Resistant 1 Depressive Disorder, Major 1 Depression 1 Bipolar Disorder 1

Interventions

Tacrolimus 1 Sirolimus 1 Infliximab 1 Alemtuzumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02711202 2025-06-04

Sequential Targeting of Cluster of Differentiation 52 (CD52) and Tumor Necrosis Factor (TNF) Allows Early Minimization Therapy in Kidney Transplantation

Institute for Clinical and Experimental Medicine

Phase NA Completed

20 enrolled 11 charts

Kidney Transplantation

Data powered by HemOnc (CC BY 4.0) Colophon ⚡